Genes predict the brain’s reaction to smoking Have you ever wondered why some people find it so much easier to stop smoking than others? New research shows that vulnerability to smoking addiction is shaped by our genes. A study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University shows that people with genetically fast nicotine metabolism have a significantly greater brain response to smoking cues than those with slow nicotine metabolism.
Have you ever wondered why some people find it so much easier to stop smoking than others? New research shows that vulnerability to smoking addiction is shaped by our genes. A study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University shows that people with genetically fast nicotine metabolism have a significantly greater brain response to smoking cues than those with slow nicotine metabolism. Previous research shows that greater reactivity to smoking cues predicts decreased success at smoking cessation and that environmental cues promote increased nicotine intake in animals and humans. This new finding that nicotine metabolism rates affect the brain’s response to smoking may lead the way for tailoring smoking cessation programs based on individual genetics.<!--break-->
Two projects led by McGill professors are among the 17 that will receive a total of $28 million over six years to help science and engineering graduates add job skills to their academic achievements, thanks to the Natural Sciences and Engineering Research Council of Canada’s (NSERC) CREATE program.
Creativity, teamwork, determination (possibly accompanied by blood, sweat and tears) are some of the skills honed by grade 6 – 8 students participating in the All Science Challenge, a unique, one-day, highly charged competition hosted by Let’s Talk Science on May 25 at The Neuro- the Montreal Neurological Institute and Hospital of McGill University and the McGill University Health Centre.
“Don’t be safe, be brilliant” a saying by philosopher George Santayana was a favourite of world-renowned scientist Dr. David Colman, late director of the Montreal Neurological Institute and Hospital at McGill University and McGill University Health Centre.
More than 50 members of The Neuro's staff are conducting laboratory and clinical studies related to MS. They employ the finest scientific equipment--from brain imaging scanners to the latest cell biology tools-to study the disease in all its aspects and at every stage. The Neuro's basic scientists and clinical physicians cooperate closely to translate research into patient therapies.
Now, a new review of human brain imaging studies published by Cell Press in the journal Trends in Endocrinology and Metabolism suggests that a major reason for the dramatic increase in obesity may be a heightened sensitivity to heavily advertised and easily accessible high-calorie foods.
A cholesterol drug commonly prescribed to reduce cardiovascular disease risk restores blood vessel function in a mouse model of Alzheimer’s disease, according to a study in the April 4 issue of The Journal of Neuroscience.
The Neuro gained international renown as a centre of advanced epilepsy research and treatment thanks to the work of Dr. Penfield and such colleagues as the surgeon, Theodore Rasmussen, and the pioneer in electroencephalography (EEG), Herbert Jasper. Their illustrious example has inspired groundbreaking epilepsy research and treatment at the Neuro for more than 70 years.
A collaborative study by scientists at Baylor College of Medicine (BCM) and the Montreal Neurological Institute of McGill University, and published March 20 in the online, open access journal PLoS Biology, has discovered that mutations in the same gene that encodes part of the vital machinery of the mitochondrion can cause neurodegenerative disorders in both fruit flies and humans.